Great news! We have a few private offices available. Book a visit to check them out!

Great news! We have a few private offices available. Book a visit to check them out!

Home » StemSight

Overview

We are developing off-the-shelf cell therapies for corneal blindness using human induced pluripotent stem cells. Our firsts product aims to cure a rare form of blindness called limbal stem cell deficiency that currently can’t be cured. In the future, we aim to tackle the global corneal tissue shortage with stem cell based solutions.

About

Stage
Research, Pre-revenue
Business Model
B2B
Funding
Seed
Industries
Biomaterials and implants, Healthcare & Life Science
Technology
Biotechnology
Sustainable
SDG 3 - Good Health and Well-Being
Development Goals

Media

Åkerlundinkatu 8, 33100 Tampere